Literature DB >> 21543851

Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain.

Noriko Handa1, Tetsuo Takagi, Shinya Saijo, Seiichiro Kishishita, Daisuke Takaya, Mitsutoshi Toyama, Takaho Terada, Mikako Shirouzu, Atsushi Suzuki, Suni Lee, Toshimasa Yamauchi, Miki Okada-Iwabu, Masato Iwabu, Takashi Kadowaki, Yasuhiko Minokoshi, Shigeyuki Yokoyama.   

Abstract

AMP-activated protein kinase (AMPK) is a serine/threonine kinase that functions as a sensor to maintain energy balance at both the cellular and the whole-body levels and is therefore a potential target for drug design against metabolic syndrome, obesity and type 2 diabetes. Here, the crystal structure of the phosphorylated-state mimic T172D mutant kinase domain from the human AMPK α2 subunit is reported in the apo form and in complex with a selective inhibitor, compound C. The AMPK α2 kinase domain exhibits a typical bilobal kinase fold and exists as a monomer in the crystal. Like the wild-type apo form, the T172D mutant apo form adopts the autoinhibited structure of the `DFG-out' conformation, with the Phe residue of the DFG motif anchored within the putative ATP-binding pocket. Compound C binding dramatically alters the conformation of the activation loop, which adopts an intermediate conformation between DFG-out and DFG-in. This induced fit forms a compound-C binding pocket composed of the N-lobe, the C-lobe and the hinge of the kinase domain. The pocket partially overlaps with the putative ATP-binding pocket. These three-dimensional structures will be useful to guide drug discovery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543851     DOI: 10.1107/S0907444911010201

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  26 in total

1.  Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase.

Authors:  Obi C Umunakwe; Adam C Seegmiller
Journal:  J Lipid Res       Date:  2014-05-24       Impact factor: 5.922

2.  AMP-activated protein kinase is a key intermediary in GnRH-stimulated LHβ gene transcription.

Authors:  Josefa Andrade; Jessica Quinn; Richad Z Becker; Margaret A Shupnik
Journal:  Mol Endocrinol       Date:  2013-03-21

3.  Activation of AMP-activated protein kinase regulates hippocampal neuronal pH by recruiting Na(+)/H(+) exchanger NHE5 to the cell surface.

Authors:  Tushare Jinadasa; Elöd Z Szabó; Masayuki Numat; John Orlowski
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinase.

Authors:  Christopher N Johnson; Valerio Berdini; Lijs Beke; Pascal Bonnet; Dirk Brehmer; Joseph E Coyle; Phillip J Day; Martyn Frederickson; Eddy J E Freyne; Ron A H J Gilissen; Christopher C F Hamlett; Steven Howard; Lieven Meerpoel; Rachel McMenamin; Sahil Patel; David C Rees; Andrew Sharff; François Sommen; Tongfei Wu; Joannes T M Linders
Journal:  ACS Med Chem Lett       Date:  2014-05-23       Impact factor: 4.345

5.  Differential effects of AMP-activated protein kinase in isolated rat atria subjected to simulated ischemia-reperfusion depending on the energetic substrates available.

Authors:  Romina Hermann; Victoria Evangelina Mestre Cordero; María de Las Mercedes Fernández Pazos; Federico Joaquín Reznik; Débora Elisabet Vélez; Enrique Alberto Savino; María Gabriela Marina Prendes; Alicia Varela
Journal:  Pflugers Arch       Date:  2017-10-14       Impact factor: 3.657

6.  AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury.

Authors:  Joshua D Stone; Avinash Narine; Patti R Shaver; Jonathan C Fox; Jackson R Vuncannon; David A Tulis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

7.  AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.

Authors:  Toby A Dite; Christopher G Langendorf; Ashfaqul Hoque; Sandra Galic; Richard J Rebello; Ashley J Ovens; Lisa M Lindqvist; Kevin R W Ngoei; Naomi X Y Ling; Luc Furic; Bruce E Kemp; John W Scott; Jonathan S Oakhill
Journal:  J Biol Chem       Date:  2018-04-25       Impact factor: 5.157

8.  DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.

Authors:  Fumi Seto-Tetsuo; Masaki Arioka; Koichi Miura; Takeru Inoue; Kazunobu Igawa; Katsuhiko Tomooka; Fumi Takahashi-Yanaga; Toshiyuki Sasaguri
Journal:  Oncogene       Date:  2021-07-24       Impact factor: 9.867

9.  Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.

Authors:  Yandong Shi; Emanuela Felley-Bosco; Thomas M Marti; Katrin Orlowski; Martin Pruschy; Rolf A Stahel
Journal:  BMC Cancer       Date:  2012-12-04       Impact factor: 4.430

10.  Acute regulation of 5'-AMP-activated protein kinase by long-chain fatty acid, glucose and insulin in rat primary adipocytes.

Authors:  Abdel Hebbachi; David Saggerson
Journal:  Biosci Rep       Date:  2012-12-13       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.